105.50
0.00
(0.00%)
At close: January 17 at 2:40:22 PM CST
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in MXN.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Michael G. Raab | President, CEO & Director | 20.8M | -- | 1965 |
| Ms. Elizabeth A. Grammer Esq. | Chief Legal & Administrative Officer and Secretary | 13.43M | -- | 1964 |
| Dr. Laura A. Williams M.D., M.P.H. | Chief Medical Officer | 13.36M | -- | 1964 |
| Mr. Justin A. Renz CPA, MBA | Chief Financial & Operations Officer | 12.54M | -- | 1972 |
| Mr. Joseph Reilly | Senior VP of Finance & Principal Accounting Officer | -- | -- | 1974 |
| Ms. Caitlin Lowie | Vice President of Corporate Communications & Investor Relations | -- | -- | -- |
| Mr. Mike Kelliher | Executive Vice President of Corporate Development & Strategy | -- | -- | 1977 |
Ardelyx, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 395
Description
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
Corporate Governance
Ardelyx, Inc.’s ISS Governance QualityScore as of April 1, 2025 is 7. The pillar scores are Audit: 7; Board: 6; Shareholder Rights: 8; Compensation: 8.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
April 30, 2025 at 10:59 AM UTC - May 5, 2025 at 12:00 PM UTC
Ardelyx, Inc. Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
B9A.F BioArctic AB (publ)
16.79
+12.46%
RPD.MU Royalty Pharma plc
28.20
0.00%
HQ1.MU Oruka Therapeutics Inc. R
7.05
+6.02%
7PO.F Poxel S.A.
0.4510
-11.39%
2HA.F Spero Therapeutics, Inc.
0.6170
+16.64%
05Y.MU Vivoryon Therapeutics NV
1.7440
-4.49%
BT3.BE Lineage Cell Therapeutics Inc
0.3800
-5.47%
PROT Proteonomix, Inc.
0.0000
0.00%
P0F.F Egetis Therapeutics AB (publ)
0.2955
-4.68%
ICY.HA Incyte Corp
52.14
+1.76%